The use of Medroxyprogesterone Acetate CI is contraindicated in the following conditions: Known or suspected pregnancy or as a diagnostic test for pregnancy; active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease; known or suspected malignancy of breast; known hypersensitivity to medroxyprogesterone acetate or any of its other ingredients; significant liver disease; undiagnosed vaginal bleeding.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
